Does the Removal of Contact Precautions for MRSA and VRE Infected Patients Change Health Care-associated Infection Rate?: A Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Objective: Update existing meta-analysis to analyze if discontinuation of contact precautions (CPs) for Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin resistant Enterococcus (VRE) colonization or infection affects hospital-associated MRSA or VRE infection rates.
Methods: We conducted a systematic review of 17 studies evaluating discontinuation of CPs for MRSA and VRE. Random-effects and fixed-effects models were used to determine the pooled risk ratios (RR) of preincidence hospital-associated infection rate to postincidence rate. Subgroup analysis was used to assess sources of heterogeneity.
Results: No significant difference between rates of hospital-associated MRSA infection before and after stopping the CPs was observed (RR, 0.84; 95% confidence internal [CI], 0.71-1.01; P = .06). An inverse association was observed between discontinuation of CPs and rates of hospital-associated VRE infection (RR, 0.82; 95% CI, 0.72-0.94; P = .005). A subgroup analysis of 6 studies that used chlorhexidine, showed no difference between rates of hospital-associated MRSA infection with discontinuation of CPs (RR, 0.83; 95% CI, 0.69-1.00; P = .05). In 5 studies that did not use chlorhexidine, there was no difference between rates of hospital-associated MRSA infection with discontinuation of CPs (RR, 1.02; 95% CI, 0.55-1.88; P= .95).
Conclusions: There was no significant difference in rates of hospital-associated MRSA infection before and after removing CPs. Additionally, there were decreased rates of hospital-associated VRE infection following stoppage of CPs.
Kelly E, Oliver M, Carney B, Shupp J Eur Burn J. 2024; 3(1):165-179.
PMID: 39604183 PMC: 11575387. DOI: 10.3390/ebj3010014.
Karunakaran S, Pless L, Ayres A, Ciccone C, Penzelik J, Sundermann A Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e97.
PMID: 38836046 PMC: 11149034. DOI: 10.1017/ash.2024.89.
Kelly G, Hudson M, Apple B, Bundage D, Lembcke B, Lasco T J Infect Prev. 2024; 25(1-2):33-37.
PMID: 38362111 PMC: 10866122. DOI: 10.1177/17571774231208312.
Mitra S, Pachpute S J Family Med Prim Care. 2024; 12(12):3262-3265.
PMID: 38361861 PMC: 10866213. DOI: 10.4103/jfmpc.jfmpc_741_23.
Karimi F, Azadi A, Omidifar N, Najafabady N, Mohammadi F, Kazemi R BMC Complement Med Ther. 2023; 23(1):391.
PMID: 37907893 PMC: 10617127. DOI: 10.1186/s12906-023-04224-0.